Cardiomyopathy
The Pediatric Cardiomyopathy Program at Monroe Carell is one of the largest programs in the country treating patients with heart problems from before birth through adulthood. We specialize in diagnosing and managing all forms of cardiomyopathy in children, including the three most common types of heart muscle disease: dilated, restrictive and hypertrophic cardiomyopathies.
For children with a family history of cardiomyopathy, we offer screening, consultation and long-term follow-up. Screening is also important for children with risk factors such as exposure to certain types of chemotherapy, neuromuscular or skeletal disorders and mitochondrial disease.
Conditions We Treat
- Left ventricular non-compaction
Meet Your Care Team
David W. BearlMD, MA
- Cardio-Oncology, Cardiovascular Medicine, Hypertrophic Cardiomyopathy, Pediatric Cardiology, Pediatric Congenital Heart Disease, Pediatric Heart, Pediatric Heart Transplant
Debra A. DoddMD, BA
- General Pediatric Cardiology, Pediatric Cardiology, Pediatric Congenital Heart Disease, Pediatric Heart, Pediatric Heart Transplant
Justin A. GodownMD, BS
- Cardiovascular Disease, Cardiovascular Medicine, Congenital Heart Disease, Congestive Heart Failure, Heart Failure, Hypertrophic Cardiomyopathy, Hypertrophic Cardiomyopathy & Inherited Disease
Why Choose the Cardiomyopathy Program at Monroe Carell
- Expert care
Our clinic offers comprehensive cardiovascular screening, including advanced cardiac MRI, exercise testing, ambulatory ECG monitoring and comprehensive genetic testing. Our three dedicated cardiologists boast expertise in pediatric cardiomyopathy, heart failure and heart transplantation.
- Recognized excellence
Our program has been named a Center of Care by the Children's Cardiomyopathy Foundation (CCF), a national nonprofit committed to improving health outcomes and quality of life for children with cardiomyopathy. We received this recognition for consistently providing high-quality cardiac care and specialized disease management for children with cardiomyopathy. Vanderbilt is also recognized as a Hypertrophic Cardiomyopathy Center of Excellence by the HCMA.
